Skip to main content

The effect of calcium supplementation on calcium and bone metabolism during load carriage in women: protocol for a randomised controlled crossover trial

Abstract

Background

Military field exercises are characterised by high volumes of exercise and prolonged periods of load carriage. Exercise can decrease circulating serum calcium and increase parathyroid hormone and bone resorption. These disturbances to calcium and bone metabolism can be attenuated with calcium supplementation immediately before exercise. This randomised crossover trial will investigate the effect of calcium supplementation on calcium and bone metabolism, and bone mineral balance, during load carriage exercise in women.

Methods

Thirty women (eumenorrheic or using the combined oral contraceptive pill, intrauterine system, or intrauterine device) will complete two experimental testing sessions either with, or without, a calcium supplement (1000 mg). Each experimental testing session will involve one 120 min session of load carriage exercise carrying 20 kg. Venous blood samples will be taken and analysed for biochemical markers of bone resorption and formation, calcium metabolism, and endocrine function. Urine will be collected pre- and post-load carriage to measure calcium isotopes for the calculation of bone calcium balance.

Discussion

The results from this study will help identify whether supplementing women with calcium during load carriage is protective of bone and calcium homeostasis.

Trial registration

NCT04823156 (clinicaltrials.gov).

Peer Review reports

Background

Military training is physically arduous [1] and involves prolonged periods of heavy load carriage [2]. The demands of military training [1] and load carriage [2] are greater in women than men, and women have a greater incidence of stress fracture [3]. These sex differences are predominantly due to the typically lower average aerobic fitness, strength, and muscle mass of women than men when completing the same tasks [1,2,3]. To maintain calcium homeostasis, blood calcium concentrations are tightly regulated [4]. Strenuous exercise disturbs calcium homeostasis; a reduction in serum calcium increases parathyroid hormone (PTH) and markers of bone resorption to maintain circulating concentrations of calcium [5,6,7]. Exercise intensity and duration influence the magnitude of the exercise-induced disturbance to calcium homeostasis [8]. In young women, load carriage exercise decreased serum ionized calcium, increased PTH, and increased fractional calcium absorption [9]. Calcium supplementation before exercise can mitigate the exercise-induced disturbances to calcium homeostasis, as shown in a series of walking and cycling studies [8]. Military training and field exercise place significant mechanical and metabolic demands on the skeleton [10,11,12,13,14], and the decrease in bone mineral density (BMD) in the axial skeleton and increase in BMD in the appendicular skeleton [15, 16] may be indicative of disturbed calcium homeostasis and/or insufficient calcium intake. A daily calcium supplement (2000 mg·d− 1) during military training prevented an increase in PTH [17], augmented tibial adaptations [5, 7], and reduced the incidence of stress fractures [18]. However, the effect of calcium supplementation before an acute bout of military load carriage on calcium and bone metabolism in women is unknown.

Biochemical markers of bone resorption and formation are inherently variable and only infer the metabolic state of bone turnover at the precise instance at which they are measured. Biochemical markers of bone resorption and formation often increase or decrease together and cannot be used to determine overall net bone mineral balance (i.e. whether bone resorption or bone formation is the prevailing process) [19]. Skulan and DePaolo (1999) [20] were the first to outline a conceptual model describing the fractionation of calcium isotopes between soft tissue and bone. Differences in isotopic composition between soft tissue and bone were reported, with bone being enriched with isotopically lighter calcium isotopes compared to soft tissue [20, 21]. Decreased BMD is associated with a net loss of calcium from the bone. Using the model formulated by Skulan and DePaolo (1999) [20], measuring changes in the natural calcium isotopic composition of calcium in the urine provides a non-invasive method to determine calcium homeostasis and calcium flux to, and from, bone [22,23,24,25]. Six, naturally occurring, stable calcium isotopes exist in the diet: 40Ca, 42Ca, 43Ca, 44Ca, 46Ca, and 48Ca. Bone formation favours the uptake of isotopically lighter calcium isotopes causing a shift in urine composition towards an isotopically heavier state [26]. When bone resorption is dominant, and calcium is lost from bone, the isotopic calcium composition of the urine becomes lighter [27]. Low calcium intake results in a negative bone calcium balance (i.e. calcium is derived from the skeleton to maintain serum calcium concentrations) [28], but the effects of military load carriage and calcium supplementation on bone calcium balance, determined from circulating and urinary calcium isotopes, is unknown.

This study will investigate the effect of calcium supplementation on calcium and bone metabolism in response to load carriage exercise (standard military fitness test; 2 h, 20 kg, 6.4 km·h− 1) in military women, a population at increased risk of stress fracture during military training compared with men [3]. It is hypothesised that calcium supplementation will attenuate the decline in serum ionized calcium and increase in PTH and bone resorption, and prevent a negative calcium balance during load carriage. A secondary aim will investigate the effect of load carriage on quadricep and hamstring strength. It is hypothesised that quadricep and hamstring strength will be lower following load carriage.

Methods

This study is a non-blinded randomised crossover controlled trial. Following the completion of a screening visit to confirm study eligibility (Pre-Screening; visit 1), each participant will complete a single load carriage exercise session on two separate occasions (visits 2 and 3) completed in a randomised order; one with a calcium supplement (Supplement) (1000 mg) and one without (Control) (Fig. 1). Block randomisation using a block size of 2 will be performed and there will be no allocation concealment. All laboratory testing will be completed at the Army Human Performance Laboratory based at the Royal Military Academy, Sandhurst, UK.

Fig. 1
figure 1

Overview of the study design.

Ca2+, calcium; Questionnaires: physical activity readiness questionnaire, menstrual history questionnaire, and Eating Attitudes Test – 26 item; Diaries: exercise and menstrual; DXA, dualenergy X-ray absorptiometry; \(\dot V\)O2max, maximal rate of oxygen uptake.

Participants

Thirty women will complete this randomised controlled crossover trial. Participants will: be aged 18 to 36 years old; have a maximal rate of oxygen uptake (\(\dot V\)O2max) of ≥ 35 mL·kg−1·min−1; will be eumenorrhoeic or using the combined oral contraceptive pill, an intrauterine system, or intrauterine device; be weight stable, defined as no change in self-reported body mass ≥ 5% over the previous 3 months; have a BMI between 18 and 30 kg·m−2, and; not be pregnant or lactating. Women will be excluded if they: have disordered eating, defined as ≥ 20 on the Eating Attitudes Test – 26 item (EAT-26); are vitamin D deficient, defined as a total 25-hydroxyvitamin D (25(OH)D) < 30 nmol·L−1; have a total areal BMD T-score of < − 1; are oligomenorrhoeic or amenorrhoeic (< 9 menstrual cycles in previous 12 months); self-report as currently smoke or vape or have stopped smoking within the previous three months; are taking any medication known to affect bone or calcium metabolism (e.g. treatment for thyroid disorders); have a history of heart, liver, or kidney disease, diabetes, or thyroid disorder; have had a stress fracture or other bone injury in the previous 12 months, or; are anaemic (haemoglobin < 12 g·dL−1).

Recruitment

Regular and Reserve military servicewomen, and female civilians, will be invited to volunteer. Individuals interested in particpating will contact the investigators, upon which they will recieve a Participant Information Sheet and be invited to a phone conversation. The study aims, requirements, right to withdraw, and risks will be outlined. This study has received favourable ethical opinion from the Ministry of Defence Research Ethics Committee (1021/MoDREC/19). During this study participants will therefore be covered by the Ministry of Defence for compensation under the provisions of the no-fault compensation scheme.

Pre-screening

Consent to participate will be obtained from all volunteers by the investigators. Participants will have the option to consent for any remaining samples to be retained for follow-up analyses related to calcium metabolism, bone health, and endocrine function.

Height and body mass

Height will be measured using a stadiometer (Seca, UK) and body mass will be measured using calibrated weighing scales (Seca, UK) with participants wearing a T-shirt and shorts.

Questionnaires and activity monitoring

Participants will be asked to complete an adjusted physical activity readiness questionnaire [29], a menstrual history questionnaire [30], and the EAT-26 questionnaire [31, 32]. Participants will be asked to declare any current medication and dietary supplement use, including hormonal contraceptives, and previous history of stress fracture. Participants will be issued a menstrual diary to record down menses dates until the end of their participation in the study to aid scheduling of load carriage sessions. Habitual exercise energy expenditure (kcal) will be measured over seven days following the pre-screen visit from raw accelerometery data during periods of purposeful exercise recorded in an exercise diary [33]. Accelerometery data will be obtained from a wrist-worn device (GENEActiv, Activinsights, UK) worn for 24 h per day and sampled at 100 Hz [33]. Purposeful exercise will be defined as training/competition sessions, including leisure or transport activities (e.g. running, cycle to work, hiking, swimming, military physical training).

Blood sample

A single venous blood sample will be drawn into vacutainers from a vein in the antecubital fossa for the measurement of haemoglobin, serum total 25(OH)D for vitamin D status and intact PTH (iPTH) [29].

Dual-energy X-ray absorptiometry (DXA)

Participants will initially complete a pregnancy test to confirm they are not pregnant. A whole-body scan (Lunar iDXA™, GE Healthcare) will be performed with participants lying supine on the scanning table. Participants will be asked to wear shorts and a T-shirt and remove any jewellery. Whole-body and regional areal BMD, T-score, fat mass, fat-free mass, and lean mass will be determined from the scan.

Maximal rate of oxygen uptake

An incremental maximal exercise treadmill test (ELG, Woodway, USA) will be performed to determine \(\dot V\)O2max [34]. Participants will run on the treadmill at a starting speed of 5 km·h−1 with the speed increased by 1 km·h−1 per minute until volitional exhaustion. Expired gases (Metalyzer 3B, Cortex, Germany) and heart rate (H10, Polar, Finland) will be measured continuously. Maximal rate of oxygen uptake will be taken as the highest 30 s average \(\dot V\)O2. Where \(\dot V\)O2max criteria is not attained (34) \(\dot V\)O2peak will be reported.

Load carriage 1 and 2

Participants who meet the inclusion criteria from pre-screening will complete two independent load carriage exercise sessions in the laboratory separated by a minimum of two weeks. Participants not taking any hormonal contraceptives will track their menstrual cycle with the provided menstrual diary and start each experimental testing session in the late lutal phase/early follicular phase (within the few days just before or after menstruation). Participants using the combined oral contraceptive pill will complete each experimental testing session during the seven day break between pill packets; participants taking back-to-back combined oral contraceptive pill packets, using an intrauterine system, or intrauterine device will be tested at any point.

In the 24 h preceding each load carriage session participants will be rested (no exhaustive exercise) and will not apply skin moisturizer. Participants will arrive at the laboratory after an overnight fast, have an indwelling cannula inserted in a vein in the antecubital fossa, and a resting blood sample taken (Fig. 2). A calcium supplement (2 × 500 mg; Calcichew) will be given to each participant completing the Supplement condition ~ 60 min before starting the load carriage exercise [8]. Sweat collectors (Macroduct Sweat Collector, ELITech Group, France) [35] will be attached to the forearm for the measurement of sweat calcium excretion during exericse. A 120 min session of load carriage exercise will be completed. The load carriage exercise is a fitness test completed by the infantry. Participants will walk 12.8 km on the treadmill at 6.4 km·h− 1 for 120 min whilst wearing a 20 kg military backpack. Expired gases, heart rate, and rating of perceived exertion will be measured throughout the exercise. The first urine void upon waking (Fig. 2), and a urine void within ~ 1 h of the cessation of load carriage, will be obtained for the measurement of calcium isotopes for the calculation of bone calcium balance. Nude body mass will be measured before and immediately after exercise for the determination of sweat loss and calculation of sweat calcium excretion; post-exercise body mass will be adjusted for water consumed ad libitum during exercise. Calcium concentration of water consumed during exercise will be recorded. Blood samples will be taken at 0 min, and then every 20 min during, and 15, 30, 60, and 90 min following, load carriage. Blood samples fractioned into serum and plasma will be analysed for markers of bone formation, bone resorption, and calcium metabolism. Whole blood will be analysed immediately for blood lactate concentration (Lactate Pro 2, Arkray, Japan), ionized calcium, haemoglobin and haematocrit (i-STAT Alinity, Abbott, USA; CHEM8+, Abbott, USA) (Fig. 2). Isokinetic (60°·s− 1 and 180°·s− 1) and isometric (90° knee flexion) maximal voluntary contraction of the knee extensors and flexors (System 4, Biodex Medical Systems, USA) will be measured before and immediately after load carriage exercise. Researchers will monitor the laboratory testing procedures to ensure adhereance to study protocols; there is no criteria for the study to be discontinued.

Biological sample collection and storage

Venous blood samples will be drawn into vacutainers for the collection of serum (SST II Advance serum separator, and silica, Becton Dickinson, USA) and plasma (K2EDTA, Becton Dickinson, USA). Serum and plasma vacutainers will stand at room temperature for 30 min before centrifugation at 3000 g 4 °C for 10 min. Serum and plasma fractions will be stored at −80 °C until analysis. Venous blood samples for the collection of whole blood will be drawn into a lithium heparin vacutainer (Becton Dickinson, USA), analysed immediately and then disposed of. Urine voids will be collected into a 1 L container; a 10 mL volume will be aspirarted into a Monovette (Sarstedt, UK) containing boric acid and stored at −80 °C until analysis. Sweat samples will be transferred to 1.5 mL microvettes and stored at −80 °C until analysis.

Calcium isotope measurement in blood, urine, and sweat

Blood (serum), urine, and sweat samples will be analysed for total calcium and the stable calcium isotopes 42Ca and 44Ca as described elsewhere [24]. Urine (1 mL) and serum (0.25 mL) will be digested in 14 mol/L HNO3 and 2 mL of H2O2 (30%), then heated to 220 °C for 45 min and dried overnight at 120 °C. Dried samples will be dissolved in 2 mol/L HNO3 to reach a calcium concentration of 25 mg/L then undergo automatic chromatographic purification (prepFAST MC, ESI, USA); a solution almost solely containing calcium will be collected with a yield of more than 85%. Calcium solutions will be dried and treated at 120 °C for 3 h with 1 mL 14 mol/L, l HNO3 and 0.5 mL of H2O2 (30%), then dissolved in 0.2 mol/L HNO3 to yield a concentration of 2.5 mg/L. A maximum of 21 samples, one blank, and one of each reference material (NIST SRM 915a, IAPSO Standard Seawater, NIST SRM 1486), and one in-house standard for urine (AK-1) or serum (SERA-1) will be collected. Calcium isotope measurements will be performed on a Multicollector-Inductively Coupled Plasma-Mass Spectrometer (MC-ICP-MS) (Neptune plus, Thermo Fisher Scientific, Bremen, Germany). The mass spectrometer is equipped with nine Faraday cups of which eight are moveable. The mass spectrometer is set up to measure masses 42, 43, 43.5, and 44 simultaneously. To prevent interfering calcium and argon hybrids (e.g. 40Ar1H2 on 42Ca) an APEX IR (ESI, Omaha, Nebraska, USA) sample introduction system is used. All measurements will be performed in medium resolution (MR, m/Δm ~ 4,000) on the interference-free plateau of the low mass side of the peaks, achieved by choosing an appropriate center cup mass of 43.687 ± 0.001 amu, verified on a daily basis (cf. [36]). Instrumental fractionation (mass bias) will be corrected by applying the standard-sample-bracketing approach. The measurement of a sample will be bracketed by measurements of a ~ 5 µg·mL calcium solution prepared from a 10,000 µg·g calcium ICP reference solution. Every sample will be measured at least four times during a session and the mean value used for further calculations. There is negligible isotope fractionation during purification (< 0.01‰) with this method. Although almost all strontium is removed from the samples during chemical preparation, samples will be monitored for doubly charged strontium (84Sr, 86Sr, and 88Sr) that can interfere with the measurement of 42Ca, 43Ca, and 44Ca (cf. [37]). Several criteria will be applied to reject data of a single measurement, a single sample, or a whole sequence [37]: a single sample will be rejected when |δ44/42Ca – 2·δ43/42Ca|>0.2‰; a single sample (4 or 5 single measurements) will be rejected when the average intensity is outside a 70 to 130% intensity window when compared to the average intensity of the reference solution from the same batch; a whole sequence will be rejected when more than one of the measured international reference materials deviates more than 0.2‰ from the literature value or the data will not fall along the mass-dependent fractionation line. The long-term 2-sigmal standard deviation reproducibility of the Ca isotope value is 0.06‰.

Biochemical markers of bone formation and bone resorption

Pre-screen and load carriage (Fig. 2) blood sample analysis will be performed at the Bioanalytical Facility, University of East Anglia (Norwich, UK) by the COBAS automated platform (Roche Diagnostics, Mannheim, Germany). Procollagen type 1 N-terminal propeptide, (P1NP), iPTH, beta carboxy-terminal cross-linking telopeptide of type 1 collagen (βCTX) and osteocalcin will be analysed in EDTA plasma, whereas albumin-adjusted calcium, phosphate, luteinising hormone, follicle stimulating hormone, oestradiol, and sex hormone binding globulin in serum. Sample analysis will be carried out according to manufacturers’ instructions and under Good Clinical and Laboratory Practice conditions. The inter-assay coefficient of variations (CV) are ≤ 3% within their respective analytical working range. LC-MS/MS will be used to measure serum testosterone, 25(OH)D3, 25(OH)D2, 24,25-dihydroxyvitamin D3 (24,25(OH)2D3), 24,25-dihydroxyvitamin D2 (24,25(OH)2D2), 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), and 1,25-dihydroxyvitamin D2 (1,25(OH)2D2), with their respective vitamin D metabolite ratio [38]. The measurement ranges of the assays are: 0–25 nmol/L for 24,25(OH)2D2 and 24,25(OH)2D3, and 15–600 pmol/L for 1,25(OH)2D2 and 1,25(OH)2D3. The mean CV for intra-assay imprecision across the measuring range of the assays are: ≤ 7.7% for 24,25(OH)2D2, 9.0% for 24,25(OH)2D3, and ≤ 7.4% for 1,25(OH)2D. The cumulative inter-assay CVs are: ≤ 10.6% for 24,25(OH)2D2, ≤ 8.9% for 24,25(OH)2D3, and ≤ 9.3% for 1,25(OH)2D. Plate-based enzyme-linked immunosorbent assay (ELISA) will be used to analyse for bone-specific alkaline phosphatase (bone ALP) (MicroVue, Quidel, San Diego, CA, USA) and sclerostin (Biomedica, Vienna, Austria) in serum. Inter-assay CV for bone ALP is ≤ 5.8%, and  < 8.5% for sclerostin.

Fig. 2
figure 2

Overview of load carriage exercise testing protocol.

aProcollagen type 1 N-terminal propeptide, bone-specific alkaline phosphatase, beta carboxy-terminal cross-linking telopeptide of type 1 collagen, albumin-adjusted calcium, ionized calcium, 44Ca:42Ca, phosphate, intact parathyroid hormone, 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, luteinising hormone, follicle stimulating hormone, oestradiol, testosterone, and sex hormone binding globulin will be measured before load carriage.

bProcollagen type 1 N-terminal propeptide, beta carboxy-terminal cross-linking telopeptide of type 1 collagen, ionized calcium, albumin-adjusted calcium, phosphate, intact parathyroid hormone, sclerostin and osteocalcin will be measured at 0 and 120 min during load carriage, then 30 and 90 min after load carriage. 44Ca:42Ca will be measured at 120 min during load carriage.

cProcollagen type 1 N-terminal propeptide, beta carboxy-terminal cross-linking telopeptide of type 1 collagen, ionized calcium, albumin-adjusted calcium, phosphate, and intact parathyroid hormone will be measured at 20, 40, 60, 80 and 100 min during load carriage, and 15 and 60 min after load carriage.

Data analyses

Data management will be conducted by the investigators. All data will be pseudo anonymised, and double data entry and value range checks will be performed. The investigators will collect and assess the outcome measurements. Exercise energy expenditure measured with raw accelerometery data [33] during periods of purposeful exercise, and recorded in the exercise diary, will be processed with the GENEAread R package from CRAN [39] using a cusomized, openly available script [33, 40]. The ratio of 44Ca to 42Ca (44Ca:42Ca) in urine, blood and sweat will be measured following published standard procedures [24, 25]. The calcium isotopic composition is reported as δ44/42Ca in parts per thousand (‰):

$$\begin{array}{l}{\delta ^{44/42}}Ca{\rm{ }}\left( {{\% _0}} \right){\rm{ }} = {\rm{ }}\\\left[ {{{\left( {^{44}Ca{/^{42}}Ca} \right)}_{Sample}}/{{\left( {^{44}Ca{/^{42}}Ca} \right)}_{Reference}}} \right]{\rm{ - }}1\end{array}$$

Change between pre- and post-load carriage urine samples will be calculated for each load carriage session.

Statistical analyses

No previous studies have been published investigating calcium balance through natural calcium isotope ratios in response to exercise or calcium supplementation, therefore the required sample size for this study is calculated based upon data from high and low calcium diets to reflect the Control (no calcium) and Supplement (1000 mg calcium) conditions within this study. The required sample size was calculated in R (version 4.1.1) using the ‘pwr’ package based on testing the null hypothesis that there will be no difference in calcium balance between Control and Supplement conditions. Based on differences in calcium balance between women on a high (~ 1500 mg·d− 1) and low (~ 300 mg·d− 1) calcium diet (108.6 ± 127.9 vs. − 95.2 ± 24.6 mg·d− 1, d = 2.21) [28], and men on a low (376 mg·d− 1) and moderate (857 mg·d− 1) calcium diet (10.0 ± 6.0 vs. 0.1 ± 1.8 parts per ten thousand, d = 2.24) [22], it is anticipated that 5 people per group will be required to detect a difference in calcium balance between the Control group and Supplement group with an α of 0.05 and a 1 – ß of 0.90. The data from these trials were using chronic diets rather than acute supplementation and so we anticipate that the effect we will see will be much smaller. Therefore, a second sample size calculation was performed from PTH concentration (a secondary outcome) in response to exercise. Based on a 18.86 to 26.83 pg·mL− 1 [41,42,43] higher serum PTH during exercise without calcium supplementation compared with calcium supplementation (following a calcium meal [1352 ± 53 vs. 46 ± 7 mg [42]] or calcium drink [1000 mg·L− 1 [41]; 486 mg·L− 1 [43]), it is anticipated that 26 people will be required to detect a difference in serum PTH concentration (d = 0.667) between the Control group and Supplement group with an α of 0.05 and a 1 – ß of 0.90. A total sample of 30 will allow us to detect an effect of d ≥ 0.75 with an α of 0.01 and a 1 – ß of 0.90.

A per-protocol analysis will be performed. Significance will be accepted as p < 0.05.

Primary outcomes

The absolute change in urine calcium balance (44Ca:42Ca) from pre- to post-load carriage will be compared between the Control condition and Supplement condition using a one-way analysis of covariance (ANCOVA) with pre-load carriage calcium balance (either as a ratio, or both the numerator and denominator) as the covariate. The minimal important difference in absolute change in urine calcium balance between the Control condition and Supplement condition is not known.

Secondary outcomes

Circulating measures of calcium and bone metabolism during load carriage will be compared between Control and Supplement conditions, and changes in knee flexor and extensor strength will be compared between pre- and post-load carriage, using linear mixed models with the restricted maximum likelihood estimation to allow incorporation of incomplete data. Time and group (Control or Supplement) will be assigned as fixed effects and participant will be assigned as random effects to account for within participant correlation for repeated measures. Within exercise data will be compared between trials using paired sample t-tests.

Discussion

Military women are at increased risk of stress fracture during military training compared with men [3], and strategies to protect the skeletal health of this population are required. Women in the UK Armed Forces are exposed to heavy prolonged periods of load carriage. Load carriage exercise has been found to increase PTH, decrease serum ionized calcium, and increase fractional calcium absorption [9]. The effect is likely intensity dependent with higher intensity exercise causing the rise in PTH [44], which appears to make women more susceptible to PTH increases during basic military training [14]. Acute calcium supplementation can attenuate acute disturbances in calcium homeostasis during exercise [45], but whether a similar effect is present in military load carriage is unknown. The results from this study will help identify whether supplementing women with calcium during load carriage is protective of calcium and bone metabolism. Understanding the influence of load carriage on calcium and bone homeostasis, and whether the provision of a calcium supplement attenuates exercise-induced disruption to calcium homeostasis, will improve our understanding of the effect of military activities on skeletal metabolism and support evidence-based nutritional policies. Energy supplementation during military field exercises and operations are often ineffective in eliminating energy deficits [46] and other solutions are required to protect bone health in energy deficits. These data will have important utility in other physically arduous occupations and in female athletes. Data from this study will be presented to the Ministry of Defence and published where possible.

Data Availability

The data that support the findings of this study will be available from The Ministry of Defence but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. However data will be available from the authors upon reasonable request and with permission of The Ministry of Defence.

Abbreviations

25(OH)D:

25-hydroxyvitamin D

ANCOVA:

analysis of covariance

βCTX:

beta carboxy-terminal cross-linking telopeptide of type 1 collagen

Bone ALP:

bone-specific alkaline phosphatase

BMD:

bone mineral density

BMI:

body mass index

Ca2+ :

calcium

CV:

coefficient of variation

DXA:

dual-energy X-ray absorptiometry

EAT-26:

Eating Attitudes Test – 26 item

ELISA:

enzyme-linked immunosorbent assayu

iPTH:

intact parathyroid hormone

LC-MS/MS:

liquid chromatography tandem mass spectrometry

MC-ICP-MS:

Multicollector-Inductively Coupled Plasma-Mass Spectrometer

P1NP:

procollagen type 1 N-terminal propeptide

PTH:

parathyroid hormone

\(\dot V\)O2max :

maximal rate of oxygen uptake

\(\dot V\)O2peak :

peak oxygen uptake

\(\dot V\)O2 :

volume of oxygen per minute

References

  1. O’Leary TJ, Saunders SC, McGuire SJ, Venables MC, Izard RM. Sex differences in Training loads during british Army Basic Training. Med Sci Sports Exerc. 2018;50(12):2565.

    Article  PubMed  Google Scholar 

  2. O’Leary TJ, Saunders SC, McGuire SJ, Izard RM. Sex differences in neuromuscular fatigability in response to load carriage in the field in British Army recruits. J Sci Med Sport. 2018;21(6):591–5.

    Article  PubMed  Google Scholar 

  3. O’Leary TJ, Wardle SL, Rawcliffe AJ, Chapman S, Mole J, Greeves JP. Understanding the musculoskeletal injury risk of women in combat: the effect of infantry training and sex on musculoskeletal injury incidence during british Army basic training. BMJ Mil Health. 2020.

  4. Mundy GR, Guise TA. Hormonal control of calcium homeostasis. Clin Chem. 1999;45(8):1347–52.

    Article  CAS  PubMed  Google Scholar 

  5. Wherry SJ, Swanson CM, Wolfe P, Wellington T, Boxer RS, Schwartz RS, et al. Bone biomarker response to walking under different thermal conditions in older adults. Med Sci Sports Exerc. 2019;51(8):1599–605.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Kohrt WM, Wherry SJ, Wolfe P, Sherk VD, Wellington T, Swanson CM, et al. Maintenance of serum Ionized Calcium during Exercise attenuates parathyroid hormone and bone resorption responses. J Bone Miner Res. 2018;33(7):1326–34.

    Article  CAS  PubMed  Google Scholar 

  7. Kohrt WM, Wolfe P, Sherk VD, Wherry SJ, Wellington T, Melanson EL et al. Dermal calcium loss is not the primary determinant of PTH secretion during Exercise. Med Sci Sports Exerc. 2019.

  8. Wherry SJ, Swanson CM, Kohrt WM. Acute catabolic bone metabolism response to exercise in young and older adults: a narrative review. Exp Gerontol. 2022;157:111633.

    Article  CAS  PubMed  Google Scholar 

  9. Gaffney-Stomberg E, Nakayama A, Lutz L, O’Brien K, Staab J. Load carriage Exercise increases calcium absorption and Retention in Healthy Young Women. Curr Developments Nutr. 2021;5(Supplement2):1290.

    Article  Google Scholar 

  10. Izard RM, Fraser WD, Negus C, Sale C, Greeves JP. Increased density and periosteal expansion of the tibia in young adult men following short-term arduous training. Bone. 2016;88:13–9.

    Article  PubMed  Google Scholar 

  11. O’Leary TJ, Izard RM, Walsh NP, Tang JCY, Fraser WD, Greeves JP. Skeletal macro- and microstructure adaptations in men undergoing arduous military training. Bone. 2019;125:54–60.

    Article  PubMed  Google Scholar 

  12. O’Leary TJ, Wardle SL, Gifford RM, Double RL, Reynolds RM, Woods DR, et al. Tibial macrostructure and microarchitecture adaptations in women during 44 weeks of Arduous Military Training. J Bone Miner Res. 2021;36(7):1300–15.

    Article  PubMed  Google Scholar 

  13. O’Leary TJ, Rice HM, Greeves JP. Biomechanical basis of Predicting and preventing lower limb stress fractures during arduous training. Curr Osteoporos Rep. 2021.

  14. O’Leary TJ, Izard RM, Tang JCY, Fraser WD, Greeves JP. Sex differences in tibial adaptations to arduous training: an observational cohort study. Bone. 2022;160:116426.

    Article  PubMed  Google Scholar 

  15. O’Leary TJ, Gifford RM, Double RL, Reynolds RM, Woods DR, Wardle SL, et al. Skeletal responses to an all-female unassisted Antarctic traverse. Bone. 2019;121:267–76.

    Article  PubMed  Google Scholar 

  16. Casez JP, Fischer S, Stussi E, Stalder H, Gerber A, Delmas PD, et al. Bone mass at lumbar spine and tibia in young males–impact of physical fitness, exercise, and anthropometric parameters: a prospective study in a cohort of military recruits. Bone. 1995;17(3):211–9.

    Article  CAS  PubMed  Google Scholar 

  17. Gaffney-Stomberg E, Lutz LJ, Rood JC, Cable SJ, Pasiakos SM, Young AJ, et al. Calcium and vitamin D supplementation maintains parathyroid hormone and improves bone density during initial military training: a randomized, double-blind, placebo controlled trial. Bone. 2014;68:46–56.

    Article  CAS  PubMed  Google Scholar 

  18. Lappe J, Cullen D, Haynatzki G, Recker R, Ahlf R, Thompson K. Calcium and vitamin d supplementation decreases incidence of stress fractures in female navy recruits. J Bone Miner Res. 2008;23(5):741–9.

    Article  CAS  PubMed  Google Scholar 

  19. Skulan J, Bullen T, Anbar AD, Puzas JE, Shackelford L, LeBlanc A, et al. Natural calcium isotopic composition of urine as a marker of bone mineral balance. Clin Chem. 2007;53(6):1155–8.

    Article  CAS  PubMed  Google Scholar 

  20. Skulan J, DePaolo DJ. Calcium isotope fractionation between soft and mineralized tissues as a monitor of calcium use in vertebrates. Proceedings of the National Academy of Sciences. 1999;96(24):13709-13.

  21. Heuser A, Eisenhauer A. A pilot study on the use of natural calcium isotope (44Ca/40Ca) fractionation in urine as a proxy for the human body calcium balance. Bone. 2010;46(4):889–96.

    Article  CAS  PubMed  Google Scholar 

  22. Rangarajan R, Mondal S, Thankachan P, Chakrabarti R, Kurpad AV. Assessing bone mineral changes in response to vitamin D supplementation using natural variability in stable isotopes of calcium in urine. Sci Rep. 2018;8(1):16751.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Channon MB, Gordon GW, Morgan JL, Skulan JL, Smith SM, Anbar AD. Using natural, stable calcium isotopes of human blood to detect and monitor changes in bone mineral balance. Bone. 2015;77:69–74.

    Article  CAS  PubMed  Google Scholar 

  24. Eisenhauer A, Muller M, Heuser A, Kolevica A, Gluer CC, Both M, et al. Calcium isotope ratios in blood and urine: a new biomarker for the diagnosis of osteoporosis. Bone Rep. 2019;10:100200.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Heuser A, Frings-Meuthen P, Rittweger J, Galer SJG. Calcium isotopes in human urine as a Diagnostic Tool for Bone loss: additional evidence for Time Delays in Bone Response to Experimental Bed Rest. Front Physiol. 2019;10:12.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Morgan JL, Skulan JL, Gordon GW, Romaniello SJ, Smith SM, Anbar AD. Rapidly assessing changes in bone mineral balance using natural stable calcium isotopes. Proc Natl Acad Sci U S A. 2012;109(25):9989–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Heuser A, Eisenhauer A. A pilot study on the use of natural calcium isotope (44Ca/40Ca) fractionation in urine as a proxy for the human body calcium balance. Bone. 2010;46(4):889–96.

    Article  CAS  PubMed  Google Scholar 

  28. O’Brien KO, Abrams SA, Liang LK, Ellis KJ, Gagel RF. Bone turnover response to changes in calcium intake is altered in girls and adult women in families with histories of osteoporosis. J Bone Miner Res. 1998;13(3):491–9.

    Article  PubMed  Google Scholar 

  29. Medicine ACoS. ACSM’s guidelines for exercise testing and prescription. Lippincott williams & wilkins; 2013.

  30. De Souza MJ, Nattiv A, Joy E, Misra M, Williams NI, Mallinson RJ et al. 2014 female athlete triad coalition consensus statement on treatment and return to play of the female athlete triad: 1st International Conference held in San Francisco, California, May 2012 and 2nd International Conference held in Indianapolis, Indiana, May 2013. British journal of sports medicine. 2014;48(4):289-.

  31. Eating Arttitudes Test. https://www.eat-26.com/downloads/. Accessed 05 May 2023.

  32. Garner DM, Olmsted MP, Bohr Y, Garfinkel PE. The eating attitudes test: psychometric features and clinical correlates. Psychol Med. 1982;12(4):871–8.

    Article  CAS  PubMed  Google Scholar 

  33. Gifford RM, Greeves JP, Wardle SL, O’Leary TJ, Double RL, Venables M, et al. Measuring the Exercise component of Energy availability during arduous training in women. Med Sci Sports Exerc. 2021;53(4):860–8.

    Article  CAS  PubMed  Google Scholar 

  34. Poole DC, Jones AM. Measurement of the maximum oxygen uptake Vo2max: Vo2peak is no longer acceptable. J Appl Physiol. 2017;122(4):997–1002.

    Article  CAS  PubMed  Google Scholar 

  35. Choi D-H, Kitchen GB, Stewart KJ, Searson PC. The dynamic response of sweat chloride to changes in exercise load measured by a wearable sweat Sensor. Sci Rep. 2020;10(1):1–10.

    Google Scholar 

  36. Wieser ME, Buhl D, Bouman C, Schwieters J. High precision calcium isotope ratio measurements using a magnetic sector multiple collector inductively coupled plasma mass spectrometer. J Anal At Spectrom. 2004;19(7):844–51.

    Article  CAS  Google Scholar 

  37. Morgan JLL, Gordon GW, Arrua RC, Skulan JL, Anbar AD, Bullen TD. High-Precision Measurement of Variations in Calcium Isotope Ratios in urine by multiple collector inductively coupled plasma Mass Spectrometry. Anal Chem. 2011;83(18):6956–62.

    Article  CAS  PubMed  Google Scholar 

  38. Tang JCY, Nicholls H, Piec I, Washbourne CJ, Dutton JJ, Jackson S, et al. Reference intervals for serum 24,25-dihydroxyvitamin D and the ratio with 25-hydroxyvitamin D established using a newly developed LC-MS/MS method. J Nutr Biochem. 2017;46:21–9.

    Article  CAS  PubMed  Google Scholar 

  39. The Comprehensive R Archive Network (CRAN). https://cran.r-project.org/. Accessed 05 May 2023.

  40. Activinsights. https://open.geneactiv.org. Accessed 05 May 2023.

  41. Barry DW, Hansen KC, Van Pelt RE, Witten M, Wolfe P, Kohrt WM. Acute calcium ingestion attenuates exercise-induced disruption of calcium homeostasis. Med Sci Sports Exerc. 2011;43(4):617.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Haakonssen EC, Ross ML, Knight EJ, Cato LE, Nana A, Wluka AE et al. The effects of a calcium-rich pre-exercise meal on biomarkers of calcium homeostasis in competitive female cyclists: a randomised crossover trial. PLoS ONE. 2015;10(5).

  43. Guillemant J, Accarie C, Peres G, Guillemant S. Acute effects of an oral calcium load on markers of bone metabolism during endurance cycling exercise in male athletes. Calcif Tissue Int. 2004;74:407–14.

    Article  CAS  PubMed  Google Scholar 

  44. Scott JP, Sale C, Greeves JP, Casey A, Dutton J, Fraser WD. The role of exercise intensity in the bone metabolic response to an acute bout of weight-bearing exercise. J Appl Physiol. 2011;110(2):423–32.

    Article  CAS  PubMed  Google Scholar 

  45. Sherk VD, Wherry SJ, Barry DW, Shea KL, Wolfe P, Kohrt WM. Calcium supplementation attenuates disruptions in Calcium Homeostasis during Exercise. Med Sci Sports Exerc. 2017;49(7):1437–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. O’Leary TJ, Wardle SL, Greeves JP. Energy Deficiency in Soldiers: the risk of the Athlete Triad and relative Energy Deficiency in Sport Syndromes in the military. Front Nutr. 2020;7:142.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

RS is funded by a National Institute for Health Research (NIHR), (CDF-2016-09-038; Career Development Fellowship) for this research project. This publication presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. TJO, CVC and JPG thank Dr Erin GaffneyStomberg for her guidance with the study design.

Funding

This work is being funded by the Ministry of Defence (Army), UK.

Author information

Authors and Affiliations

Authors

Contributions

CVC and TJO wrote the manuscript. TJO, CVC and JPG designed the study. SLW, RS and AE contributed to study design. AE, JCYT and WDF will perform biochemical analyses. All authors read and approved the final version of the manuscript.

Corresponding author

Correspondence to Thomas J. O’Leary.

Ethics declarations

Competing interests

AE is a consultant for Osteolabs GmbH. The other authors have no competing interest to declare.

Ethics approval and consent to participate

This study has received favourable ethical opinion from the Ministry of Defence Research Ethics Committee (MoDREC); protocol number 1021/MoDREC/19. Informed consent will be obtained from all volunteers by the investigators. All methods carried out in this study will be conducted in accordance with the relevant guidelines and regulations.

Consent for publication

Not applicable.

Study sponsor

British Army, Army Headquarters, Andover, UK. The study sponsor had no role in the study design, data collection, data analysis and interpretation, or writing of the report.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Coombs, C.V., Wardle, S.L., Shroff, R. et al. The effect of calcium supplementation on calcium and bone metabolism during load carriage in women: protocol for a randomised controlled crossover trial. BMC Musculoskelet Disord 24, 496 (2023). https://doi.org/10.1186/s12891-023-06600-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12891-023-06600-w

Keywords